Our findings suggest that combining a panel of selected biomarkers improves diagnostic accuracy for CRC detection, with IGFBP2 and mSEPT9 performing similarly as individual biomarkers in early and advanced stages. This evidence concerns the gene IGFBP2 and colorectal carcinoma.